Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05438> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05438 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05438 label "IDM-4 [drugbank:DB05438]" assertion.
- drugbank:DB05438 seeAlso DB05438 assertion.
- drugbank:DB05438 description "IDM-4 is an immuno-designed molecule that completed phase I/II of investigation for the treatment of Leukemia. It is a monoclonal antibody-specific antigen that can selectively target cancer-affected cells by coupling with tumor cell-killing MAK cells, which are derived from the patient's own monocytes. Trials of this drug have most likely been discontinued by the manufacturer." assertion.
- drugbank:DB05438 identifier "drugbank:DB05438" assertion.
- drugbank:DB05438 title "IDM-4" assertion.
- drugbank:DB05438 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05438 drugbank_vocabulary:drugbank-id "DB05438" assertion.
- drugbank:DB05438 bio2rdf_vocabulary:x-identifiers.org DB05438 assertion.
- drugbank:DB05438 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05438" assertion.
- drugbank:DB05438 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05438 bio2rdf_vocabulary:identifier "DB05438" assertion.